Lv5
1100 积分 2023-05-24 加入
ISCT MSC Committee Statement on the US FDA Approval of Allogenic Bone-Marrow Mesenchymal Stromal Cells
18天前
已关闭
An Oral Interleukin-23–Receptor Antagonist Peptide for Plaque Psoriasis
23天前
已完结
Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the international Vitiligo Task Force—Part 2: Specific treatment recommendations
25天前
已完结
Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the International Vitiligo Task Force Part 1: towards a new management algorithm
25天前
已完结
Polymyositis and dermatomyositis
1个月前
已完结
Dermatomyositis
2个月前
已完结
An Oral Interleukin-23–Receptor Antagonist Peptide for Plaque Psoriasis
4个月前
已完结
English version of Japanese guidance for the use of oral Janus kinase inhibitors (JAK1 and TYK2 inhibitors) in the treatments of psoriasis
4个月前
已完结
TYK2 inhibition with deucravacitinib ameliorates erosive oral lichen planus
5个月前
已完结
Type 1 interferons: A target for immune-mediated inflammatory diseases (IMIDs)
5个月前
已完结
皖公网安备34019202002308
